Updated
AbivaxABVX · Healthcare
$85.73+1.85%
Market cap$6.8B
IndustryBiotechnology
Abivax (ABVX) Superinvestor holders
11 of the superinvestors we track hold Abivax (ABVX) in their latest 13F filings, $233M in total.
Summary
The largest holder is Ensign Peak (Ensign Peak Advisors), with $67M, 0.1% of the portfolio.
In their latest quarter: 1 opened a new position, 5 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ensign Peak Ensign Peak Advisors |
Trimmed | 504,471 | $67M | 0.1% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Added | 418,657 | $56M | 0.1% | Q2 2026 |
| Jennison Associates | Trimmed | 196,524 | $26M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 187,335 | $25M | 0.1% | Q2 2026 |
| Wilmot Harkey Nantahala Capital Management |
Trimmed | 133,759 | $18M | 1.1% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
Added | 122,000 | $16M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 90,357 | $12M | 0.0% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
Added | 61,251 | $6M | 0.1% | Q3 2026 |
| Lee Ainslie Maverick Capital |
New position | 40,000 | $5M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 5,028 | $670,031 | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 2,500 | $333,150 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 11 |
| Q1 2026 | 10 |
| Q4 2025 | 11 |
| Q3 2025 | 10 |
| Q2 2025 | 3 |
| Q1 2025 | 4 |
| Q4 2024 | 3 |
| Q3 2024 | 3 |
Questions about Abivax
Which superinvestors own Abivax?
11 of the superinvestors we track hold Abivax (ABVX) in their latest 13F filings, $233M in total. Ensign Peak, Brandon Haley, Jennison Associates, Paul Tudor Jones, Wilmot Harkey, Tom Steyer.
Who is the largest superinvestor holder of ABVX?
The largest holder is Ensign Peak (Ensign Peak Advisors), with $67M, 0.1% of the portfolio.
From Abivax's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.